Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Emerging evidence has illustrated the importance of epigenomic reprogramming in cancer, with altered post-translational modifications of histones contributing to pathogenesis. However, the contributions of histone modifiers to breast cancer progression are unclear, and how these processes vary between molecular subtypes has yet to be adequately add...
Alternative Titles
Full title
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_08e7c695e7a0496dbcbb93d281626f1b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08e7c695e7a0496dbcbb93d281626f1b
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-018-04864-8
